241 related articles for article (PubMed ID: 2171305)
1. [In vitro sensitivity to antiviral agents of herpes simplex viruses isolated from patients with herpetic keratitis].
Mori Y; Inoue Y; Shimomura Y; Manabe R
Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):484-7. PubMed ID: 2171305
[TBL] [Abstract][Full Text] [Related]
2. Analysis of herpes simplex virus isolated from patients with recurrent herpes keratitis exhibiting "treatment-resistance" to 5-iodo-2'-deoxyuridine.
Hirano A; Yumura K; Kurimura T; Katsumoto T; Moriyama H; Manabe R
Acta Virol; 1979 May; 23(3):226-30. PubMed ID: 41435
[TBL] [Abstract][Full Text] [Related]
3. [Acquired idoxuridine resistance of herpes simplex virus. Clinical data (author's transl)].
Colin J; Chastel C
Sem Hop; 1978 Oct 18-25; 54(33-36):1071-2. PubMed ID: 220719
[TBL] [Abstract][Full Text] [Related]
4. Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
Charles SJ; Gray JJ
Br J Ophthalmol; 1990 May; 74(5):286-8. PubMed ID: 2162190
[TBL] [Abstract][Full Text] [Related]
5. Effects on herpes simplex virus type 1 of combined use of interferon-beta and anti-herpetic agents in vitro.
Naito T; Shiota H; Nitta K; Mimura Y
Jpn J Ophthalmol; 1990; 34(1):15-21. PubMed ID: 2163462
[TBL] [Abstract][Full Text] [Related]
6. Ocular herpes simplex infection. A clinical evaluation of virus isolation and studies on iodo-deoxyuridine resistance.
Nordenfelt L; Nordenfelt E
Acta Ophthalmol (Copenh); 1977 Dec; 55(6):919-26. PubMed ID: 202139
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of three antiviral drugs in mice herpetic keratitis.
Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
Jpn J Ophthalmol; 1989; 33(1):125-31. PubMed ID: 2543857
[TBL] [Abstract][Full Text] [Related]
8. Use of the immunoperoxidase technique for estimation of susceptibility of herpes simplex virus to IDU.
Sakata H; Yoshida H; Hiyama N; Kondo H; Hirakawa Y; Iwamoto T
Acta Ophthalmol (Copenh); 1983 Dec; 61(6):961-8. PubMed ID: 6318509
[TBL] [Abstract][Full Text] [Related]
9. Simplified test for detecting the resistance of herpes simplex virus to acyclovir.
Agut H; Aubin JT; Ingrand D; Blanc S; Clayton AL; Chantler SM; Huraux JM
J Med Virol; 1990 Jul; 31(3):209-14. PubMed ID: 2167944
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of therapeutic activity of idoxuridine and acyclovir in experimentally-induced herpetic keratitis in rabbits (author's transl)].
Colin C; Chastel C; Quillien MC; Renard G
J Fr Ophtalmol; 1981; 4(1):33-43. PubMed ID: 7217623
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
Yao YF; Inoue Y; Kase T; Uchihori Y; Mori Y; Ohashi Y
Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
[TBL] [Abstract][Full Text] [Related]
12. [Influence of various factors on the proliferation of herpes simplex virus. II. With regard to the problem of tolerance of the herpes simplex virus for IDU].
Oshima K
Nippon Ganka Gakkai Zasshi; 1967 Aug; 71(8):1211-6. PubMed ID: 4295686
[No Abstract] [Full Text] [Related]
13. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
[TBL] [Abstract][Full Text] [Related]
14. "Treatment-resistance" to idoxuridine in herpetic keratitis.
Coleman VR; Tsu E; Jawetz E
Proc Soc Exp Biol Med; 1968 Dec; 129(3):761-5. PubMed ID: 4302153
[No Abstract] [Full Text] [Related]
15. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates.
Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ
J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of herpes simplex virus resistant to nucleoside analogs.
Katz E; Rosenblat O; Pisanty S
Oral Surg Oral Med Oral Pathol; 1991 Sep; 72(3):296-9. PubMed ID: 1656355
[TBL] [Abstract][Full Text] [Related]
17. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis.
van Velzen M; van de Vijver DA; van Loenen FB; Osterhaus AD; Remeijer L; Verjans GM
J Infect Dis; 2013 Nov; 208(9):1359-65. PubMed ID: 23901090
[TBL] [Abstract][Full Text] [Related]
18. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J
Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058
[TBL] [Abstract][Full Text] [Related]
19. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
Harmenberg J; Wahren B; Sundqvist VA; Levén B
J Antimicrob Chemother; 1985 May; 15(5):567-73. PubMed ID: 2989239
[TBL] [Abstract][Full Text] [Related]
20. Emergence of cross-resistant herpes simplex virus following topical drug therapy in rabbit keratitis.
Fardeau C; Langlois M; Mathys B; Rafales P; Nugier F; Godard V; Aymard M; Denis J
Curr Eye Res; 1991; 10 Suppl():151-8. PubMed ID: 1650663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
